Medmonk is a technology platform that helps fight non-adherence. It enables pharmacists to provide financial assistance to patients who are unable to pay for their medications.
Medmonk is a Y Combinator company in the Winter 2012 batch. Its directory entry describes it as: A tool for pharmacists to find funding for patients who are unable to…. The founders listed are Abbas Mehdi (Founder), Somaira Punjwani (Founder) (Y Combinator directory entry, November 23, 2011).
Sell to companies like Medmonk? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2011-11-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Medmonk.
Free to see. No signup.
More on Medmonk and the records around it.
Get an email when Medmonk changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Medmonk raises, hires or launches. No email unless you switch it on.
Watch Medmonk →Get the full cited report on Medmonk
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Medmonk: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Medmonk is a technology platform that helps fight non-adherence. It enables pharmacists to provide financial assistance to patients who are unable to pay for their medications. We partner with pharmaceutical companies, pharmacies, physicians, and health plans to improve outcomes by promoting access to chronic therapy. Medmonk is based on the premise that it's in everyone's best interest for medications to be used regardless of price. Patients get the care they need, insurers are protected against larger claims, and pharmaceutical companies and pharmacies get maximum use of their medications.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Medmonk: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medmonk covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist MedmonkYou get an alert in MentionFox the next time this company shows up.
If you're behind Medmonk: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for Medmonk. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-medmonk